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Background: Celiac disease (CD) is an immune-mediated
disorder associated with some autoimmune liver diseases,
including primary biliary cirrhosis, autoimmune hepatitis
and primary sclerosing. In addition, there are contradictory
reports on association of chronic hepatitis C (HCV) and celiac
disease. The aim of this study was to determine the preva-
lence of untreated celiac disease and Hepatitis C Virus in
Iranian pregnant women and assess the outcome of preg-
nancy compared to non-celiac cases.
Methods: In this cross sectional study, 827 pregnant
women were recruited for this study during the period of
January 2007- February 2009. The mean age was 26.07
and SD 5.35 and mean pregnancy 5.4 months. Data were
obtained through questionnaires distributed during preg-
nancy. The questionnaire included questions about GI
symptoms and infections during pregnancy. They underwent
a total IgA test and antihuman IgA class antitissue transglu-
taminase (tTGA) antibodies for celiac disease and samples
also screened for anti- HCV antibodies by Third generation
enzyme linked immunosorbent assay.
Results: From 827 pregnant women 27 (3.26%) had a
positive serology for tTGA. Only two samples (0.24%) were
anti-HCV positive and one of them had positive tTG-IgA.
Eleven cases from 827 had IgA deﬁciency and none of them
were positive for IgG-tTG. Out of the 27 diagnosed women,
three had low birth weight babies and four had a history of
miscarriage.
Conclusion: Routine screening of HCV in CD patients is
not recommended, however, the presence of CD should be
considered in the setting of clinical deterioration during the
pregnancy.
doi:10.1016/j.ijid.2010.02.2006
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Background: Recent analysis of ART program data in
Georgia showed that end-stage liver disease is leading cause
E
t
ots e233
f death among HIV/HCV co infected patients on ART after
nitiation of ART program in 2005. Therefore, treatment of
epatitis C among HIV infected individuals is essential for
ustaining success of ART in Georgia and to improve sur-
ival rates of HIV infected patients. HCV treatment response
ate and sustained viral suppression after antiviral treat-
ent largely depends on the HCV genotypes along with the
nﬂuence of HIV co- infection itself. The objective of this ret-
ospective study was to study the prevailing genotypes and
ubtypes of HCV virus in a cohort of HIV infected patients in
rder to obtain the preliminary data.
Methods: We analyzed 1490 HIV infected patients co
nfected with HCV virus. Among them 59% were HCV coin-
ected. Measurement of HCV RNA viral load was done by
OBAS TaqMan HCV-2.0 Test and HCV genotyping by reverse
ybridization line probe assay using VERSANT HCV Genotype
it 2.0 respectively.
Results: Detectable HCV RNA was found among 680
atients (91.%). Less than 10 Iu/ml was found among among
7 (9%). This numbers indicate low rate of self clearance
f the virus among HIV persons. Greater HCV RNA levels
ere associated with a greater chance to be infected with
CV genotypes 1. Most prevalent genotypes were genotype 1
ccounting for (41.6%), followed by genotype 3 (34.7%) and
(17.6%), inter genotype recombinants were found among
.8%.
Conclusion: Study demonstrated high prevalence of HCV
nfection among HIV-infected patients and reveals 1 as
redominant genotype. The differences of prevailing HCV
enotypes among general population and HIV co infected
roup was probably attributed to the different methods
or sample selection used. Another option can be possi-
le inﬂuence of diverse transmission networks among HIV
nfected group. The high number of intergenotype recom-
inants might be results of continues parenteral exposure
o different HCV genotypes during drug injection parapher-
alia. Study highlights and strengthens the need for careful
ollow-up of HCV/HIV co infected patients, effective man-
gement and therapies against HCV in order to reduce liver
elated death rates in patients on ART.
oi:10.1016/j.ijid.2010.02.2007
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Background: Long-term lamivudine (LAM), adefovir (ADV)
nd entecavir (ETV) treatment has been found to induce
he emergence of drug-resistant hepatitis B virus (HBV) in a
igniﬁcant number of patients with chronic hepatitis B infec-
ion. The aim of our study was to evaluate the LAM, ADV and
TV mutations detected in our patient group.
Methods: Fifteen patients diagnosed with chronic hepati-
is B were enrolled in this study. The patient group consisted
f those who had received two years of treatment with
